Evidence for thromboxane biosynthesis in established cell lines derived from human lung adenocarcinomas.

[1]  Bonnie F. Sloane,et al.  Inhibition by prostacyclin of the tumor cell-induced platelet release reaction and platelet aggregation. , 1987, Journal of the National Cancer Institute.

[2]  G. Tuszynski,et al.  Thrombospondin, a potentiator of tumor cell metastasis. , 1987, Cancer research.

[3]  A. Gee,et al.  Effect of human tumor cells on platelet aggregation: potential relevance to pattern of metastasis. , 1987, Cancer research.

[4]  R. Fanelli,et al.  Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor. , 1987, Cancer research.

[5]  E. Bleecker,et al.  Detection and Quantitation of Eicosanoids by Combined Gas Chromatography-Mass Spectrometry , 1987 .

[6]  E. Bleecker,et al.  Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. , 1986, Prostaglandins.

[7]  M. Mccarty,et al.  An antithrombotic role for nutritional antioxidants: implications for tumor metastasis and other pathologies. , 1986, Medical hypotheses.

[8]  Bonnie F. Sloane,et al.  Platelet-Tumor Cell Interactions as a Target for Antimetastatic Therapy , 1986 .

[9]  R. Fanelli,et al.  Prostaglandin and thromboxane synthesis by Lewis lung carcinoma during growth. , 1985, Cancer research.

[10]  S. Karpatkin,et al.  Effect of antiplatelet antibody on the development of pulmonary metastases following injection of CT26 colon adenocarcinoma, Lewis lung carcinoma, and B16 amelanotic melanoma tumor cells into mice. , 1984, Cancer research.

[11]  N. Semeraro,et al.  Relationship between Procoagulant Activity and Metastatic Capacity of Tumor Cells , 1984 .

[12]  P. Mehta.  Potential role of platelets in the pathogenesis of tumor metastasis. , 1984, Blood.

[13]  Bonnie F. Sloane,et al.  A review of prostaglandins and the treatment of tumor metastasis. , 1983, Acta Clinica Belgica.

[14]  Bonnie F. Sloane,et al.  Prostacyclin and thromboxanes. Implications for their role in tumor cell metastasis. , 1983, Biochemical pharmacology.

[15]  W. Whimster,et al.  Prostaglandins and human lung carcinomas. , 1982, British Journal of Cancer.

[16]  K. Honn,et al.  Control of tumor growth and metastasis with prostacyclin and thromboxane synthetase inhibitors: evidence for a new antitumor and antimetastatic agent (BAY g 6575). , 1982, Progress in clinical and biological research.

[17]  W. Hubbard,et al.  Preparation of deuterated arachidonic acid. , 1981, Prostaglandins.

[18]  J. Fogh,et al.  Absence of HeLa cell contamination in 169 cell lines derived from human tumors. , 1977, Journal of the National Cancer Institute.

[19]  B. Samuelsson.  Prostaglandins and Thromboxanes , 1977, NATO Advanced Study Institutes Series.

[20]  J. Oates,et al.  Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. , 1975, The New England journal of medicine.

[21]  M. Hamberg,et al.  Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Fogh,et al.  New Human Tumor Cell Lines , 1975 .

[23]  S. Aaronson,et al.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. , 1973, Journal of the National Cancer Institute.

[24]  C. Stewart,et al.  Antimetastatic effects associated with platelet reduction. , 1968, Proceedings of the National Academy of Sciences of the United States of America.